Back to Index
Rima Jubran, MD
Associate Professor of Clinical Pediatrics
Designated Institute official For CHLA
CHL 4650 Sunset Blvd Off Campus Los Angeles
+1 323 361 5639


Rima Fuad Jubran, MD, MPH, MACM is medical director of the Retinoblastoma Program in the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, where she cares for children with central nervous system tumors, retinoblastoma and neuroblastoma. In addition, Dr. Jubran is deputy division head for education and director of the Hematology-Oncology Fellowship Program. She received her medical degree from Case Western Reserve University School of Medicine, Cleveland, Ohio, and her masters of public health at George Washington University, Washington, D.C. Following her residency at Rainbow Babies and Children's Hospital in Cleveland, she completed a fellowship in pediatric hematology/oncology at Children's National Medical Center, Washington, D.C. Dr. Jubran is a member of the retinoblastoma committee of the national Children's Oncology Group and chair of a clinical trial for patients with advanced intraocular retinoblastoma. In addition, she serves on the study committees of two other retinoblastoma studies. Her investigations focus on retinoblastoma and Langerhans cell histiocytosis, a cancer-like condition that may be treated with chemotherapy. A frequent lecturer and author, she is an active member of the international Histiocytosis Society.


Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 Apr; 64(4). View in: PubMed

Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 Dec; 37(4):400-403. View in: PubMed

Measuring pediatric hematology-oncology fellows' skills in humanism and professionalism: A novel assessment instrument. Pediatr Blood Cancer. 2016 Nov 3. View in: PubMed

Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatr Blood Cancer. 2016 Oct; 63(10):1723-30. View in: PubMed

Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec; 2(2):76-9. View in: PubMed

Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2162-6. View in: PubMed

Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. View in: PubMed

Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31. View in: PubMed

Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. View in: PubMed

Clinical outcomes of radiation therapy in the management of langerhans cell histiocytosis. Am J Clin Oncol. 2014 Dec; 37(6):592-6. View in: PubMed

Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution. J Pediatr Orthop. 2014 Dec; 34(8):825-30. View in: PubMed

Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: The Children's Hospital Los Angeles experience. Br J Ophthalmol. 2014 Aug; 98(8):1061-5. View in: PubMed

Simultaneous colonic adenocarcinoma and medulloblastoma in a 12-year-old with biallelic deletions in PMS2. J Pediatr. 2013 Aug; 163(2):601-3. View in: PubMed

Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013 Apr; 60(4):688-93. View in: PubMed

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013 Feb; 60(2):175-84. View in: PubMed

Graduate medical education changes: Yes we can or enough already? Pediatr Blood Cancer. Graduate medical education changes: Yes we can or enough already? Pediatr Blood Cancer. 2012 Dec 15; 59(7):1168-72. View in: PubMed

An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012 Dec 15; 59(7):1324-6. View in: PubMed

Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer. 2012 Jun; 58(6):905-9. View in: PubMed

Symptoms before and after Posterior Fossa Surgery in Pediatric Patients. Pediatr Neurosurg. 2012; 48(1):21-5. View in: PubMed

Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. J Neurooncol. 2011 Jul; 103(3):673-80. View in: PubMed

The role of chemotherapy in pediatric clival chordomas. J Neurooncol. 2011 Jul; 103(3):657-62. View in: PubMed

Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation. Int J Cancer. 2011 May 15; 128(10):2393-404. View in: PubMed

High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010 Jul 15; 55(1):149-52. View in: PubMed

Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer. 2010 Jul 15; 55(1):42-6. View in: PubMed

Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer. 2010 Mar; 54(3):384-7. View in: PubMed

High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Cancer. 2009 Jul 1; 115(13):2956-63. View in: PubMed

Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Pediatr Blood Cancer. 2008 Oct; 51(4):479-84. View in: PubMed

Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatr Blood Cancer. 2008 Mar; 50(3):715-7. View in: PubMed

A case of composite neuroblastoma composed of histologically and biologically distinct clones. Pediatr Dev Pathol. 2007 May-Jun; 10(3):229-32. View in: PubMed

Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005 Jul; 45(1):37-42. View in: PubMed

Disordered respiratory control in children with partial cerebellar resections. Pediatr Pulmonol. 2005 Jul; 40(1):88-91. View in: PubMed

Central nervous system germ cell tumors: controversies in diagnosis and treatment. Oncology (Williston Park). 2005 May; 19(6):705-11; discussion 711-2, 715-7, 721. View in: PubMed

Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol. 2004 Jan; 26(1):31-4. View in: PubMed

GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis. 2000 Mar; 30(3):569-71. View in: PubMed

Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light. Ther Drug Monit. 1998 Apr; 20(2):236-9. View in: PubMed

Powered bySC CTSI